1Llach F , Massry SG. On the mechanism of secondary hyperparathyroidism in moderate renal insufficiency. J Clin Endocrinol Metab , 1985,61:601.
2Hercz G, Pei Y, Greenwood C, et al. Saiphoo C, Goodman WG, Seffe GV, Fenton S. Sherrard DJ: Aplastic osteodystrophy without aluminum: The role of "suppressed" parathyroid function. Kidney Int, 1993,44 : 860 - 866.
3Hercz G, Cobum JW. Prevention of phosphate retention and hyperphosphatemia in ruemia. Kidney Int , 1987,32 (Suppl 22) :215.
5Blumenkartz M,J , Kopple JD , Moran J K, et al. Metabolic balance studies and dietary protein requirements in patients undergoing CAPD. Kidney Int , 1982 ,21:849.
6Delmez JA , Slatopolsky E , Martin KF , et al. Mineral , vitamin D and parathyroid hormone in CAPD. Kidney Int , 1982 ,21:862.
二级参考文献10
1Levin NM, Hullbert-Shearon TE, Str-awdesman RL et al. Which causes of death are relatedto hyperphremia in hemodialysis patients[J]? J Am Soc Nephrol, 1998,9:217a.
2Braun J , Oldendorf M, Moshage W et al. Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients[J]. Am J Kidney Dis,1996,27:394-401.
3Goodman WG, Goldin J, Kuizon BD et al. Coronary artery calcification in young adults with end-stage renal disease who are undergoing dialysis[J]. N Engl J Med, 2000,342:1478-1483.
4Raggi P, Boulay A, Chasan-Tabers et al. Cardiac calcification in adult hemodialysis patients. A link between end stage renal disease and cardiovascular disease[J]. J Am Coll Cardiol, 2002,39 :695 -701.
5Mucsi I, Heroz G, Uldall R, et al. Control of serum phosphate without any phosphate binders in patients treated with nocturnal hemodialysis[J]. Kidney Int, 1998,53:1399-1442
6Locatelli F, Cannata-Andia JB, Drueke TB, et al. Management of disturbance of calcium and phosphate metabolism in chronic renal insufficiency, with emphasis on the control of hyperphosphatemia[J]. Nephrol Dial Transplant, 2002,17:723-731.
7Chertow GM, Burke SK, Raggi P et al. Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients[J]. Kidney Int, 2002,62:245-252.
8D'Haese PC, Spasovski GB, Sikole A, et al. A multicenter study on the effects of lanthanum carbonate and calcium carbonate on renal bone diasease in dialysis patients[J]. Kidney Int, 2003,63:73-78.
9Eknoyan G, Levin A, Levin NW, et al. National Kidney Foundation Bone metabolism and disease in chronic kidney disease[J]. Am J Kidney Dis, 2003, 42[suppl 3]:1-201
10Block GA, Hullbert-Shearon TE, Levin NW, et al. Association of serum phosphorus and calcium phosphate products with mortality risk in chronic hemodialysis patients: A national study[J]. Am J Kidney Dis, 1998,31:607-617.
